Kaidi Ren
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Neurology top 10%
Papers in
-
- Mitochondrial Function and Pathology 12
- Epigenetics and DNA Methylation 3
- Inflammasome and immune disorders 3
-
- Ferroptosis and cancer prognosis 9
- Co-authors
- Yang Yang (22 shared papers)Xiu‐Ju Luo (9 shared papers)Yi Luan (13 shared papers)Ying Luan (8 shared papers)Shaokang Pan (5 shared papers)Qi Feng (6 shared papers)Jun Peng (7 shared papers)Jie Yang (2 shared papers)
- Journals
- Frontiers in Pharmacology (6 papers)International Immunopharmacology (4 papers)Oxidative Medicine and Cellular Longevity (3 papers)Cell Death Discovery (2 papers)Advanced Science (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Kaidi Ren
44 papers receiving 1.1k citations
Kaidi Ren's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 191
- Neurology 68
- Pulmonary and Respiratory Medicine 241
- Aging 13
- Molecular Biology 477
Countries citing papers authored by Kaidi Ren
This map shows the geographic impact of Kaidi Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaidi Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaidi Ren more than expected).
Fields of papers citing papers by Kaidi Ren
This network shows the impact of papers produced by Kaidi Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaidi Ren. The network helps show where Kaidi Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaidi Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quercetin Ameliorates Diabetic Kidney Injury by Inhibiting Ferroptosis via Activating Nrf2/HO-1 Signaling Pathway Hit paper breakdown → | 2023 | 117 |
| 2 | 2022 | 88 | |
| 3 | 2016 | 65 | |
| 4 | 2023 | 57 | |
| 5 | 2021 | 55 | |
| 6 | 2024 | 50 | |
| 7 | 2015 | 39 | |
| 8 | 2019 | 38 | |
| 9 | 2016 | 36 | |
| 10 | 2021 | 34 | |
| 11 | 2022 | 34 | |
| 12 | 2023 | 32 | |
| 13 | 2023 | 31 | |
| 14 | 2019 | 27 | |
| 15 | 2023 | 27 | |
| 16 | 2024 | 26 | |
| 17 | 2022 | 25 | |
| 18 | 2024 | 24 | |
| 19 | 2023 | 23 | |
| 20 | 2022 | 20 |
About Kaidi Ren
Kaidi Ren is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Neurology, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (12 papers), Ferroptosis and cancer prognosis (9 papers), Autophagy in Disease and Therapy (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Trace Elements in Health (4 papers), interferon and immune responses (3 papers), Epigenetics and DNA Methylation (3 papers) and Inflammasome and immune disorders (3 papers). The work is most often cited by research in Cancer Research (191 citations), Neurology (68 citations), Pulmonary and Respiratory Medicine (241 citations), Aging (13 citations) and Molecular Biology (477 citations). Kaidi Ren has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yang Yang, Xiu‐Ju Luo, Yi Luan, Ying Luan, Shaokang Pan, Qi Feng, Jun Peng, Jie Yang, Xiaoyue Yu and Dongwei Liu. Their work appears in journals such as Frontiers in Pharmacology, International Immunopharmacology, Oxidative Medicine and Cellular Longevity, Cell Death Discovery and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.